Breast Cancer Clinical Trial
Safety of Pregnancy in BRCA Mutated Breast Cancer Patients
Summary
The present study aims at refining the understanding of the effect of pregnancy on breast cancer outcomes in the specific population of BRCA mutated patients with known history of breast cancer.
Eligibility Criteria
Inclusion Criteria:
Diagnosis of invasive breast cancer between January 2000 and December 2012;
Breast cancer diagnosis at the age of ≤ 40 years;
Known presence of germline BRCA mutation.
Exclusion Criteria:
Known BRCA mutation with no diagnosis of invasive breast cancer;
Diagnosis of ovarian cancer or other malignancies with no history of invasive breast cancer;
Diagnosis of hereditary or familiar invasive breast cancer without BRCA mutation or with BRCA genes not tested.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02215, United States
Brussels , , Belgium
Brussels , , Belgium
Leuven , , Belgium
São Paulo , , Brazil
Bordeaux , , France
Lyon , , France
Paris , , France
Paris , , France
Rouen , , France
Villejuif , , France
Jerusalem , , Israel
Tel Aviv , , Israel
Tel Aviv , , Israel
Aviano , , Italy
Bergamo , , Italy
Candiolo , , Italy
Genova , , Italy
Milan , , Italy
Modena , , Italy
Padova , , Italy
Pavia , , Italy
Roma , , Italy
Mexico City , , Mexico
Warsaw , , Poland
Lisbon , , Portugal
Barcelona , , Spain
Palma De Mallorca , , Spain
Valencia , , Spain
Lugano , , Switzerland
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.